List of Excipients in Branded Drug CETIRIZINE HCL

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	FD&C YELLOW NO. 6
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	GELATIN
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	GLYCERIN
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	MANNITOL
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	POLYETHYLENE GLYCOL

Generic Drugs Containing CETIRIZINE HCL

Company	Ingredient	NDC	Excipient
GERI-CARE PHARMACEUTICAL CORP	cetirizine	57896-992	HYPROMELLOSE
GERI-CARE PHARMACEUTICAL CORP	cetirizine	57896-992	LACTOSE MONOHYDRATE
GERI-CARE PHARMACEUTICAL CORP	cetirizine	57896-992	MAGNESIUM STEARATE
GERI-CARE PHARMACEUTICAL CORP	cetirizine	57896-992	POLYETHYLENE GLYCOL
GERI-CARE PHARMACEUTICAL CORP	cetirizine	57896-992	POLYSORBATE 80

What are the Most Frequently-Used Excipients in CETIRIZINE HCL?

# Of NDCs	Excipient
3	CELLULOSE, MICROCRYSTALLINE
1	CROSCARMELLOSE SODIUM
4	HYPROMELLOSE
4	LACTOSE MONOHYDRATE
4	MAGNESIUM STEARATE

Excipient Strategy and Commercial Opportunities for Cetirizine HCl

Last updated: February 28, 2026

What are the key excipient strategies used in Cetirizine HCl formulations?

Cetirizine HCl, a second-generation antihistamine, is primarily marketed in tablet, orally disintegrating tablet (ODT), and syrup forms. Excipient strategies focus on optimizing drug stability, bioavailability, patient convenience, and manufacturability.

Core excipient strategies include:

• Disintegrants: For ODT formulations, superdisintegrants such as croscarmellose sodium or sodium starch glycolate are used to facilitate rapid dissolution.
• Binders: In tablets, binders like povidone or microcrystalline cellulose ensure tablet integrity.
• Fillers: Lactose monohydrate, microcrystalline cellulose, or dibasic calcium phosphate provide bulk and influence disintegration and dissolution.
• Lubricants: Magnesium stearate reduces friction during compression.
• Flavoring agents and sweeteners: For syrups and ODTs, flavors like cherry or orange and sweeteners such as aspartame or sucralose enhance patient acceptance.
• Wetting agents: Polysorbates improve dissolution rates in liquid formulations.

Formulation innovations focus on:

• Use of taste-masking agents in suspensions and ODTs.
• Development of fast-dissolving formulations to improve compliance.
• Incorporation of stability-enhancing excipients for extended shelf life.

What are the commercial opportunities associated with excipient choices in Cetirizine HCl?

Excipient selection influences patentability, formulation stability, manufacturing cost, and market differentiation.

Market differentiation opportunities:

• Novel excipient combinations enable patents for new dosage forms, such as films or buccal tablets.
• Patient-centric formulations, like flavor-enhanced syrups or rapidly disintegrating tablets, target specific segments such as pediatrics.
• Extended shelf life via stabilization excipients reduces logistic costs and enhances marketability.

Cost considerations:

• Optimization reduces excipient quantity and simplifies processes, decreasing production costs.
• Use of globally approved excipients avoids regulatory hurdles, accelerating market entry.

Patent landscape:

• Combining specific excipients with cetirizine HCl can generate new patents.
• Patents on taste-masked formulations hold strategic value for pediatric and OTC markets.

Regulatory aspects:

• Use of GRAS (Generally Recognized As Safe) excipients simplifies approvals.
• Novel excipient combinations may require additional safety data, impacting time to market.

How do excipient choices impact the regulatory and manufacturing landscape?

Regulatory agencies like the FDA and EMA emphasize excipient safety and consistency.

• Quality control: Stringent testing of excipient batches ensures uniformity.
• Regulatory approval: Clear documentation of excipient safety enhances approval processes.
• Manufacturing: Compatibility of excipients with process parameters reduces quality issues and waste.

Manufacturers often prefer excipients with established profiles and proven efficacy to navigate regulatory pathways efficiently.

What trends are shaping future excipient strategies in Cetirizine HCl?

• Use of natural excipients: Plant-derived ingredients appeal to clean-label markets.
• Functional excipients: These improve bioavailability or stability without complex formulations.
• Nano- and micro-sized excipients: Enhance dissolution and absorption.
• Personalized formulations: Custom excipients tailored to specific patient populations.

The focus remains on improving patient compliance, reducing manufacturing costs, and expanding patent portfolios.

---

Key Takeaways

• Excipient strategies for Cetirizine HCl center on rapid disintegration, taste masking, stability, and manufacturability.
• Innovations in excipient combinations create opportunities for new dosage forms and patent extensions.
• Regulatory considerations favor the use of safe, well-characterized excipients to streamline approvals.
• Future trends include natural, functional, and nano-sized excipients to optimize delivery and shelf life.

---

5 FAQs

1. What are common excipients in Cetirizine HCl formulations?
Disintegrants, binders, fillers, lubricants, flavorants, and wetting agents are standard. Choices depend on dosage form, e.g., croscarmellose sodium for ODTs, lactose for tablets.

2. How does excipient selection affect patentability?
Unique combinations and innovative use in novel dosage forms can qualify for patent protection, especially if they improve stability or patient experience.

3. Are natural excipients viable for Cetirizine HCl?
Yes. Natural excipients like starches or plant-derived stabilizers are gaining attention for clean-label and regulatory compliance, with ongoing research to ensure effectiveness.

4. What challenges exist in formulation and manufacturing?
Ensuring excipient compatibility, controlling batch variability, and meeting regulatory safety standards require thorough testing and validation.

5. How do excipient choices influence market expansion?
Patient-friendly formulations, such as flavored syrups or quick-dissolving tablets, expand access to pediatric or geriatric populations, increasing market reach.

---

References

1. U.S. Food and Drug Administration. (2022). Guidance for Industry: Excipients in Drug Products.
2. European Medicines Agency. (2021). Guidelines on excipients in medicinal products.
3. Cross, P., & Taylor, L. (2020). Advances in oral formulation excipients. International Journal of Pharmaceutics, 580, 119276.
4. Kaur, J., & Singh, N. (2019). Formulation and evaluation of orally disintegrating cetirizine tablets. Drug Development and Industrial Pharmacy, 45(2), 242–250.